OBJECTIVE: To determine the prevalence of multidrug-resistant tuberculosis (MDR-TB) among patients with new smear-positive pulmonary TB in Port-au-Prince, Haiti. METHODS: Sputum samples were cultured from 1 006 patients newly diagnosed with TB in 2008. The core region of the rpoB gene that is associated with resistance to rifampin was sequenced. All isolates with rpoB mutations were sent to the New York State reference laboratory for conventional drug susceptibility testing (DST). All isolates were also tested with the GenoType MTBDRplus line-probe assay. RESULTS: Mycobacterium tuberculosis was isolated from 906 patients. Twenty-six (2.9%) of the isolates had missense mutations or deletions in rpoB and were resistant to rifampin by DST. All 26 were also resistant to isoniazid and classified as MDR-TB. Forty-six control isolates without rpoB mutations were found to be rifampin sensitive by DST. The GenoType MTBDRplus line-probe assay correctly identified 26 MDR-TB strains. It misclassified one pansusceptible isolate as rifampin resistant. CONCLUSIONS: This study shows an MDR-TB prevalence of 2.9% in newly diagnosed TB patients in Haiti and suggests that rpoB sequencing and hybridization assays are good screening tools for early detection of MDR-TB.
OBJECTIVE: To determine the prevalence of multidrug-resistant tuberculosis (MDR-TB) among patients with new smear-positive pulmonary TB in Port-au-Prince, Haiti. METHODS: Sputum samples were cultured from 1 006 patients newly diagnosed with TB in 2008. The core region of the rpoB gene that is associated with resistance to rifampin was sequenced. All isolates with rpoB mutations were sent to the New York State reference laboratory for conventional drug susceptibility testing (DST). All isolates were also tested with the GenoType MTBDRplus line-probe assay. RESULTS:Mycobacterium tuberculosis was isolated from 906 patients. Twenty-six (2.9%) of the isolates had missense mutations or deletions in rpoB and were resistant to rifampin by DST. All 26 were also resistant to isoniazid and classified as MDR-TB. Forty-six control isolates without rpoB mutations were found to be rifampin sensitive by DST. The GenoType MTBDRplus line-probe assay correctly identified 26 MDR-TB strains. It misclassified one pansusceptible isolate as rifampin resistant. CONCLUSIONS: This study shows an MDR-TB prevalence of 2.9% in newly diagnosed TBpatients in Haiti and suggests that rpoB sequencing and hybridization assays are good screening tools for early detection of MDR-TB.
Authors: Patrice Joseph; Patrice Severe; Severine Ferdinand; Kye Seng Goh; Christophe Sola; David W Haas; Warren D Johnson; Nalin Rastogi; Jean W Pape; Daniel W Fitzgerald Journal: AIDS Date: 2006-02-14 Impact factor: 4.177
Authors: J L Malone; S F Paparello; J D Malone; H E Hill; K A Conrad; J W Myers; S R Lillibridge; P J Weiss Journal: Clin Infect Dis Date: 1994-11 Impact factor: 9.079
Authors: Tanya A Halse; Justine Edwards; Phyllis L Cunningham; William J Wolfgang; Nellie B Dumas; Vincent E Escuyer; Kimberlee A Musser Journal: J Clin Microbiol Date: 2010-01-27 Impact factor: 5.948
Authors: Oksana Ocheretina; Yves Mary Merveille; Marie-Marcelle Mabou; Vincent E Escuyer; Sherry A Dunbar; Warren D Johnson; Jean W Pape; Daniel W Fitzgerald Journal: J Clin Microbiol Date: 2013-05-08 Impact factor: 5.948
Authors: Jean W Pape; Patrice D Severe; Daniel W Fitzgerald; Marie M Deschamps; Patrice Joseph; Cynthia Riviere; Vanessa Rouzier; Warren D Johnson Journal: J Acquir Immune Defic Syndr Date: 2014-01-01 Impact factor: 3.731
Authors: Macarthur Charles; Stalz Charles Vilbrun; Serena P Koenig; Lauren M Hashiguchi; Marie Marcelle Mabou; Oksana Ocheretina; Jean W Pape Journal: Am J Trop Med Hyg Date: 2014-07-28 Impact factor: 2.345
Authors: Oksana Ocheretina; Vincent E Escuyer; Marie-Marcelle Mabou; Gertrude Royal-Mardi; Sean Collins; Stalz C Vilbrun; Jean W Pape; Daniel W Fitzgerald Journal: PLoS One Date: 2014-03-05 Impact factor: 3.240